Oncology News

Oncology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Mortarini R et al. - The results provide evidence for development of impaired STAT signaling in response to IL-2, along with clinical evolution of the disease, in melanoma patients' T cells.

Related Articles

Identification of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation in association with neuroblastoma progression
BMC Cancer, 12/09/09    Relevance Score: 47%

Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease
Expert Review of Neurotherapeutics, 11/19/09    Relevance Score: 46%

State Uses Script Data to Track Flu
HealthDataManagement, 12/08/09    Relevance Score: 45%

Exploring three-year-old children in a primary child health care situation
Journal of Child Health Care, 12/07/09    Relevance Score: 45%

State Adoption of Nursing Home Pay-For-Performance
Medical Care Research and Review, 11/19/09    Relevance Score: 45%

Today in Dermatologic Oncology...keeping you current

Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions
Human Pathology, 12/16/09

Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays
Human Pathology, 12/16/09

MK2 regulates the early stages of skin tumor promotion
Carcinogenesis, 12/16/09